These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Unusual clinical presentation of hypersensitivity reaction to abacavir. Aquilina C; Mularczyk M; Lucas F; Viraben R AIDS; 2003 Nov; 17(16):2403-4. PubMed ID: 14571198 [No Abstract] [Full Text] [Related]
5. Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients. Bellagamba R; Tommasi C; De Marco M; Narciso P J Infect; 2008 Jul; 57(1):88-90. PubMed ID: 18514915 [No Abstract] [Full Text] [Related]
7. 1592 (abacavir): do not rechallenge after hypersensitivity reaction. James JS AIDS Treat News; 1997 Dec; (No 285):1, 5. PubMed ID: 11364916 [TBL] [Abstract][Full Text] [Related]
8. Severe hypersensitivity reactions following reintroduction of abacavir. AIDS Read; 2000 Sep; 10(9):525. PubMed ID: 11019447 [No Abstract] [Full Text] [Related]
9. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience. Waters LJ; Mandalia S; Gazzard B; Nelson M AIDS; 2007 Nov; 21(18):2533-4. PubMed ID: 18025891 [TBL] [Abstract][Full Text] [Related]
10. Response to: Are all non-thymidine analogue backbones appropriate for treating antiretroviral-naïve patients? Brothers C; Cutrell A; Scott T; Hernandez J; Moult A Int J Clin Pract; 2006 May; 60(5):611-2; author reply 612. PubMed ID: 16700867 [No Abstract] [Full Text] [Related]
11. A near-fatal hypersensitivity reaction to abacavir: case report and literature review. Shapiro M; Ward KM; Stern JJ AIDS Read; 2001 Apr; 11(4):222-6. PubMed ID: 11392679 [TBL] [Abstract][Full Text] [Related]
13. Abacavir rechallenge has to be avoided in case of hypersensitivity reaction. Escaut L; Liotier JY; Albengres E; Cheminot N; Vittecoq D AIDS; 1999 Jul; 13(11):1419-20. PubMed ID: 10449301 [No Abstract] [Full Text] [Related]